An Worth Determining Measure? Tracking the Spread of Intestinal Disease
New research from the University of Michigan focuses on the use of visualization tools in 2017 International Gastroenterological Assessments (IGA) andor Sensitivity of Patient Test Striatal Activity (STA). The study Visual Measures of Patient Disability and Sensitivity of Patient Test Striatal Activity (STA): An International Social Science Perspective has been published in the journal Gastroenterology.
An interesting observation was that scores are higher in patients with major IGI and this implies that these patients have worse perceptions of pain and mood than those with minor IGI. Our goal is to identify value-added information associated with these scores; they should be used to protect the patient regardless of the severity of their IGI.
Bradley Ander senior author Director USF and NUS Medical School.
Bradley is also the American Gastroenterological Association (AGA) Chair for Visual Assessment and Understanding (after a committee review) at USF Health and co-directed the NIH IVA Initiative Research Training Program for patients with Inflammatory Bowel Disease and Crohns Disease.
The ISA-EndriatalICAG Inventory Used in 2017 International Gastroenterological Assessments Consortium (IGA-ISA) and WHO (IGA-CONF) Study datasets.
Prior to 2017 some studies were underway in 2014 to measure patient pain and mood which used the Near-Infrared Spectroscopic Sensitivity or NIRS exam. This technique measures how well a persons sensation of touch is translated into an electronic score. It is a simple and inexpensive way to estimate person sensory evaluation of external stimuli that have been used for clinical evaluation.
Comprehensive studies are underway to estimate patient pain and mood using IGA-ISA and other indicators when using private stool samples for IGA testing.